FDA Inspection 1241783 — Evangelos J. Giamarellos-Bourboulis, MD, PhD
The FDA completed an inspection of Evangelos J. Giamarellos-Bourboulis, MD, PhD on May 31, 2024 in Athens. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Athens (Greece)
Additional details
Clinical Investigator (CI)